Login/Register
Third COVID-19 vaccine to be available soon in India
A third coronavirus vaccine may be made available in India soon. Serum Institute of India (SII) CEO Adar Poonawala has given important information about this. Poonawalla said in a tweet that, the Serum Institute has also demonstrated excellent efficacy results in partnership with Novavax for the COVID-19 vaccine. He further added that he has applied to start testing this vaccine in India and is expected to launch the vaccine – Covovax by June 2021. According to Novovax, the Covid-19 vaccine ‘Novovax’ has shown 89.3% efficacy in its Phase 3 clinical trial in the United Kingdom. A study assessed the efficacy
Oxford COVID-19 vaccine may come in April 2021: CEO Adar Poonawala
On November 19, 2020, Adar Poonawala, CEO of Serum Institute of India, a pharma company that is making vaccines for coronaviruses in India, said that the Covid-19 Oxford vaccine could be on the market by April 2021 for health workers and the elderly. Along with this, CEO Adar Poonawala said that the Corona vaccine may be available to the public in the next 4 to 5 months. He said that the cost of two doses required to the public will be maximum of one thousand rupees but it will depend on the final results of the test and the approval
NDA After 10th
NDA (Offline & Online) Batch
SSB Interview (Offline & Online)
